What does CUSIP 75629V104 represent in this 13F holders report?

CUSIP 75629V104 is the security identifier for RXRX - RECURSION PHARMACEUTICALS, INC. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held RXRX - RECURSION PHARMACEUTICALS, INC. - COMMON STOCK in Q1 2023?

157 institutional investors reported RXRX - RECURSION PHARMACEUTICALS, INC. - COMMON STOCK for Q1 2023. Use the holders table for investor-level position and value details.

RECURSION PHARMACEUTICALS, INC. - COMMON STOCK (RXRX)

CUSIP: 75629V104

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / COMMON STOCK
Total 13F shares: 126,153,704
Total 13F value: $841,388,403
Share change: +2,420,580
Put/Call ratio: 85%
SEC-reported price per share: $6.67
Number of holders: 157
Value change: +$14,595,249
Number of buys: 82
Number of sells: 45
Shares outstanding: 525,850,455

Security key

75629V104

Report period

Q1 2023

Institutions

157

Top holders

RXRX full security history Ownership snapshot Full 13F holder table RECURSION PHARMACEUTICALS, INC. SEC filings RECURSION PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of RXRX - RECURSION PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Anchorage Capital Group, ...

Disclosed value leader

Anchorage Capital Group, ...

Comparable rows

15/15

Latest evidence

31 Dec 2022

13F Lead comparable stake: 13% Showing 1-6 of 15 holder rows.

Quick read

Anchorage Capital Group, L.L.C. leads the comparable SEC ownership view at 13%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Anchorage Capital Group, L.L.C.'s linked filing trail.

Comparable ownership Top 5

Anchorage Capital Group, L.L.C. 13%

VIKING GLOBAL INVESTORS LP 12%

GENERAL ATLANTIC, L.P. 6.2%

SB INVESTMENT ADVISERS (UK) LTD 4.7%

MIC Capital Management UK LLP 1.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Anchorage Capital Group, L.L.C.	13F Company 13F	13%	$118,054,262 69,854,593 shares	—	31 Dec 2022
VIKING GLOBAL INVESTORS LP	13F Company 13F	12%	$106,613,863 63,085,126 shares	—	31 Dec 2022
GENERAL ATLANTIC, L.P.	13F Company 13F	6.2%	$54,620,624 32,319,896 shares	—	31 Dec 2022
SB INVESTMENT ADVISERS (UK) LTD	13F Company 13F	4.7%	$41,285,333 24,429,191 shares	—	31 Dec 2022
MIC Capital Management UK LLP	13F Company 13F	1.6%	$65,163,057 8,451,758 shares	—	31 Dec 2022
Kinnevik AB (publ)	13F Company 13F	1.5%	$59,005,100 7,653,061 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

157

126,153,704

Rows available

157

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

157

Q1 2023 holders

157

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %